序号 |
标题 |
次数 |
作者 |
发布时间 |
76771 |
HS-C11-PEG 巯基-11烷烃-聚乙二醇 |
115 |
h |
2024-12-20 |
76772 |
HS-(CH2)3-EG12-OH 巯基-三烷烃-十二聚乙二醇-羟基 |
125 |
h |
2024-12-20 |
76773 |
HS-(CH2)11-EG2-OH 巯基-11烷烃-二聚乙二醇-羟基 |
104 |
h |
2024-12-20 |
76774 |
HS-(CH2)6-EG3-OH 巯基-六烷烃-三聚乙二醇-羟基 |
115 |
h |
2024-12-20 |
76775 |
(MeO)3Si-(CH2)6-OC(O)- IzoButyrate-Br (MeO)3硅-六烷烃-OC(O)- IzoButyrate-Br |
105 |
h |
2024-12-20 |
76776 |
HS-C6-DMAPS |
105 |
h |
2024-12-20 |
76777 |
Au-S-Polymer-Doxorubicin 金-硫-聚合物-阿霉素 |
109 |
h |
2024-12-20 |
76778 |
(S-(EG)3-CH2-CONH-Fluorescein)2 硫-三聚乙二醇-烷烃-CONH-荧光素 |
121 |
h |
2024-12-19 |
76779 |
Ag_55_C15COOH 银团簇55-C15-羧基 |
91 |
h |
2024-12-19 |
76780 |
Ag-S-(CH2)11-NH3+Cl- 银-硫-十一烷烃-NH3+Cl- |
134 |
h |
2024-12-19 |
76781 |
Au-S-Zwitterion 金-硫-两性离子 |
123 |
h |
2024-12-19 |
76782 |
Au_12_C11NMe3 金12碳11纳米团簇 |
114 |
h |
2024-12-19 |
76783 |
Au_55_C10COOH 金团簇55-C10-羧酸 |
96 |
h |
2024-12-19 |
76784 |
Au-S-(CH2)10-C(O)-CH3 金-硫-直链烷烃10-碳(氧)-甲烷3 |
132 |
h |
2024-12-19 |
76785 |
MC-Val-Cit-PAB-tubulysin5a ,CAS号:2055896-86-9 |
81 |
WYQ |
2024-12-19 |
76786 |
Au_55_C11NH3Cl 金55-C11-NH3Cl |
112 |
h |
2024-12-19 |
76787 |
(S-(CH2)11-(beta-Lactose(SO4Na)7)2 硫-十一烷烃-β-乳糖 |
132 |
h |
2024-12-19 |
76788 |
HS-(CH2)11-O-Disperse Red 1 十一烷烃硫醇化荧光配体 |
186 |
h |
2024-12-19 |
76789 |
HS-(CH2)16-(EG)2 -N(+)(CH3)2-CH2-COO(-) 二聚乙二醇化十六硫醇 |
132 |
h |
2024-12-19 |
76790 |
cas:103750-03-4,5-Maleimido-pentanoic NHS ester,5-马来酰亚胺戊酸NHS |
136 |
kx |
2024-12-19 |
76791 |
4-Nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate,抗体药物偶联物(ADC) |
134 |
kx |
2024-12-19 |
76792 |
cas:158913-22-5,SPDP-C6-NHS ester,琥珀酰亚胺基6-[3-(2-吡啶基二硫代)丙酰胺基]己酸酯 |
127 |
kx |
2024-12-19 |
76793 |
perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate,抗体药物偶联物(ADC) |
138 |
kx |
2024-12-19 |
76794 |
cas:663598-61-6,2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate, ADC试剂 |
109 |
kx |
2024-12-19 |
76795 |
perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate, ADC试剂 |
95 |
kx |
2024-12-19 |
76796 |
cas:160580-70-1,perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate,抗体药物偶联物(ADC) |
151 |
kx |
2024-12-19 |
76797 |
cas:252554-78-2, Fmoc-Ala-Ser(Psi(Me Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 |
159 |
kx |
2024-12-19 |
76798 |
MC-Val-Cit-PAB-Indibulin, cas:2055896-95-0 |
107 |
WYQ |
2024-12-19 |
76799 |
cas:1884578-27-1 ,Alloc-Val-Ala-PAB-PNP,N-[(2-丙烯-1-基氧基)羰基]-L-缬氨酸-N-[4-[[(4-硝基苯氧基)羰基]氧基]甲基]苯基]-L-丙氨酸酰胺 |
122 |
kx |
2024-12-19 |
76800 |
mDPR-Val-Cit-PAB-MMAE(CAS:1491152-26-1) |
107 |
WYQ |
2024-12-19 |
76801 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
110 |
wyh |
2024-12-19 |
76802 |
MC-Val-Cit-PAB-vinblastine(CAS:2055896-92-7) |
111 |
WYQ |
2024-12-19 |
76803 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
98 |
wyh |
2024-12-19 |
76804 |
MC-Val-Cit-PAB-tubulysin5a(CAS:2055896-86-9) |
109 |
WYQ |
2024-12-19 |
76805 |
N-芴甲氧羰基-四聚乙二醇-VAL-ALA-PAB, Fmoc-PEG4-Val-Ala-PAB |
137 |
kx |
2024-12-19 |
76806 |
MC-Val-Cit-PAB-clindamycin(CAS号:1639793-13-7) |
94 |
WYQ |
2024-12-19 |
76807 |
MC-Val-Cit-PAB-carfilzomib,CAS号:2055896-83-6 |
122 |
WYQ |
2024-12-19 |
76808 |
叔丁酯-四聚乙二醇-VAL-ALA-PAB,Boc-PEG4-Val-Ala-PAB |
96 |
kx |
2024-12-19 |
76809 |
MC-Val-Cit-PAB-Auristatin E,CAS号:2055896-77-8 |
124 |
WYQ |
2024-12-19 |
76810 |
MC-Sq-Cit-PAB-Gefitinib(CAS:1941168-63-3) |
184 |
WYQ |
2024-12-19 |
76811 |
HS-(CH2)m-(EG)n -N(+)(CH3)2-CH2-COO(-) 聚乙二醇化直链烷烃硫醇 |
108 |
h |
2024-12-19 |
76812 |
Mal-PEG4-Val-Ala-PAB,马来酰亚胺-四聚乙二醇-VAL-ALA-PAB |
148 |
kx |
2024-12-19 |
76813 |
MC-GGFG-DX8951(CAS:1600418-29-8) |
322 |
WYQ |
2024-12-19 |
76814 |
(HO)2-PO-S-(CH2)6-EG2-OH 硫-(2-羟基六烷-1-基)硫代磷酸酯 |
149 |
h |
2024-12-19 |
76815 |
Au_55_C11EG4Carboxybetaine 金团簇55-羧基甜菜碱 |
146 |
h |
2024-12-19 |